Back to News Items

August 2012: New Article: The Possibility of an Oral Insulin Treatment for Type 1 and Type 2 Diabetes is Near

Main Bullets:

  • Patients who require insulin to keep their blood sugar levels under control need to meet a target HbA1c levels of less than 7%
  • On July 11, 2012 Oramed, a developer of oral drug delivery systems, made an announcement regarding their latest developments in an oral anti-diabetic medication.
  • The Canadian company Generex Biotechnology announced their development of Oral-Lyn, an oral spray formulation of human insulin indicated for the treatment of type 1 and 2 diabetes.
  • The Norwegian University of Science an Technology have developed a new type of capsule designed to camouflage the insulin-producing cells to the body's immune system.
  • The total number of diabetes patients in the world is expected to grow from 275 Million to 425 Million by 2030.



Dun and Bradstreet